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Abstract
Background: AAR measurement is useful when assessing the efficacy of reperfusion therapy and novel
cardioprotective agents after myocardial infarction. Multi-slice (Typically 10-12) T2-STIR has been used widely for its
measurement, typically with a short axis stack (SAX) covering the entire left ventricle, which can result in long
acquisition times and multiple breath holds. This study sought to compare 3-slice T2-short-tau inversion recovery
(T2- STIR) technique against conventional multi-slice T2-STIR technique for the assessment of area at risk (AAR).
Methods: CMR imaging was performed on 167 patients after successful primary percutaneous coronary
intervention. 82 patients underwent a novel 3-slice SAX protocol and 85 patients underwent standard 10-slice SAX
protocol. AAR was obtained by manual endocardial and epicardial contour mapping followed by a semi-
automated selection of normal myocardium; the volume was expressed as mass (%) by two independent observers.
Results: 85 patients underwent both 10-slice and 3-slice imaging assessment showing a significant and strong
correlation (intraclass correlation coefficient = 0.92;p < 0.0001) and a low Bland-Altman limit (mean difference −0.03 ±
3.21 %, 95 % limit of agreement,- 6.3 to 6.3) between the 2 analysis techniques. A further 82 patients underwent
3-slice imaging alone, both the 3-slice and the 10-slice techniques showed statistically significant correlations with
angiographic risk scores (3-slice to BARI r = 0.36, 3-slice to APPROACH r = 0.42, 10-slice to BARI r = 0.27, 10-slice to
APPROACH r = 0.46). There was low inter-observer variability demonstrated in the 3-slice technique, which was
comparable to the 10-slice method (z = 1.035, p = 0.15). Acquisition and analysis times were quicker in the 3-slice
compared to the 10-slice method (3-slice median time: 100 seconds (IQR: 65-171 s) vs (10-slice time: 355 seconds
(IQR: 275-603 s); p < 0.0001.
Conclusions: AAR measured using 3-slice T2-STIR technique correlates well with standard 10-slice techniques, with no
significant bias demonstrated in assessing the AAR. The 3-slice technique requires less time to perform and analyse and
is therefore advantageous for both patients and clinicians.
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Background
Cardiac magnetic resonance (CMR) imaging has become
the reference standard in the quantification of ventricular
volumes, function and tissue characterisation [1]. T2
weighted imaging has been widely used in the assessment
of myocardial oedema and area at risk (AAR) following an
acute myocardial infarction (AMI) and has been hailed as
a potential ‘gold standard’ [2]. The AAR is defined as the
area of ischaemic myocardium that occurs distally to a
coronary artery occlusion and its quantification has
become crucial in assessing the efficacy of reperfusion
therapy and novel cardioprotective agents. Additionally
the AAR acts as a prognostic factor in patients following
AMI and can play a role in decision-making regarding
myocardial revascularization helping distinguish between
necrosed and viable myocardium [3, 4].
Currently methods for assessing AAR require coverage
of the whole left ventricle with the acquisition of 10–12
continuous myocardial short axis slices, with each slice
acquired with a single breath hold of 10–15 seconds.
This lengthens the overall duration of a CMR scan in
patients early after a myocardial infarction and therefore
techniques that shorten examination times may be ad-
vantageous to improve patient compliance. Furthermore,
despite advances in semi-automated software, post process-
ing and analysis of these images requires time-consuming
manual analysis.
Our goal was to assess the AAR using 3 non-contiguous
slices in comparison to conventional multi-slice contigu-
ous slices in patients following successful primary percu-
taneous coronary intervention (PPCI) for acute myocardial
infarction.
Methods
Between April 2008 and November 2012, 167 patients
with ST-segment elevation MI successfully reperfused
through primary percutaneous coronary intervention
(PPCI) and undergoing CMR within the first week after
reperfusion were studied. All of these patients had been
consented into interventional clinical trials including
stem cell trial and pharmacological intervention trials
(REGENERATE-AMI (NCT00765453), NITRITE-AMI
(NCT01584453) and myocardial oedema in acute myo-
cardial infarction (NCT00987259)) [5, 6]. These studies
were approved by local ethics committee. Patients
underwent either 3 or 10-slice T2 weighted imaging for
the assessment of the AAR.
CMR Protocol
Cardiac magnetic resonance (CMR) imaging was per-
formed on a 1 · 5 T Philips Achieva scanner with a car-
diac 32-channel phased array coil. Balanced steady-state
free precession cine imaging was used to acquire 10–12
short axis slices (8 mm slice thickness, 2 mm gap) with
one slice per breath-hold. Sequence parameters were
1.5 ms echo time (TE), 3.1 ms repetition time (TR), and
acquired voxel size was 1.8 × 1.86 mm with a typical
FOV of 360 mm in the phase encoding direction. We
acquired 45 phases with 25 % phase sharing. Parallel
imaging (SENSE) was used with an acceleration factor
of 2.0.
Myocardial oedema was assessed using fat suppressed
T2-weighted triple inversion turbo spin echo STIR
(Short tau inversion recovery) imaging (TE 80 ms, TR 2
heart beats, TSE factor 31, voxel size 1.8 ×1.8 mm).
Either 10-slices (8 mm per slice, 2 mm gap matched to
LGE/cine slices) or 3-slices (8 mm per slice, 19 mm
gap with basal, midventricular and apical slices) with
one slice per breath-hold (Fig. 1). This sequence has
previously been used and validated for assessment of
myocardial oedema and myocardial salvage index
(MSI) [7–10].
Late gadolinium enhancement (LGE) images were ac-
quired ten minutes after injection of a dose of 0 ·
2 mmol/kg of gadoterate meglumine (Dotarem). A T1-
weighted segmented inversion-recovery gradient echo
pulse sequence (TR 3.9 ms TE 1.9 ms, flip angle 15°,
voxel size of 2 × 2 mm, typical FOV 360 mm) was used
to obtain 10–12 short axis slices (matched with the
short-axis cine images) with one slice per breath-hold.
The inversion time was adjusted individually according
to a T1 scout sequence (Look-Locker). Images were ac-
quired every other heart beat with 2 signal averages.
Fig. 1 Acquisition protocol of the 3-slice and 10-slice T2-STIR techniques.
Screenshot demonstrating the different acquisition protocol levels for
basal, mid and apical slices in the 3-slice and 10-slice techniques
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Coronary angiography
All patients underwent coronary angiography according
to local cardiac catheterisation laboratory protocols and
standard primary percutaneous coronary intervention
(PCI) with insertion of at least one stent after admission
with a an acute STEMI with an ECG showing ST-
segment elevation of 0.1 mV in two or more limb leads
or 0.2 mV in two or more contiguous precordial leads,
or presumed new left bundle branch block. Flow of the
infarct related artery prior to PCI was characterized
using the TIMI system (Thrombolysis in Myocardial
Infarction) [11]. The AAR was established using angio-
graphic risk scores (BARI and modified APPROACH
scores [12, 13].
Image analysis
All analysis was performed using a dedicated software
reporting system (CVI42, Circle Cardiovascular Imaging
Inc, Calgary, Alberta, Canada). All images were anon-
ymised, batched and analysed in a blinded fashion by
two experienced CMR operators. Manual endocardial
and epicardial contours were drawn to calculate myocar-
dial mass (MM), followed by semi-automated selection
of normal myocardium with the oedema volumes being
expressed as a mass (%). Area at risk (myocardial
oedema) was described as >2SD in signal intensity from
remote normal myocardium [14]. If present, a central
core of hypointense signal within the area of increased
signal intensity (hemorrhagic infarction) was included in
the AAR [15]. Increased signal intensity from the blood
pool adjacent to the endocardium due to slow flow was
excluded. Infarct size was calculated using the full-width
half maximum method as previously described [16–18].
Infarct and oedema endocardial surface area (ESA) was
the percentage of the endocardial enhancement against
the total endocardial area. In case of discordance be-
tween operators, blinded review by a level III certified
CMR reader was performed. If myocardial haemorrhage
was present within the area of increased signal intensity
it was included in assessment area [15].
Angiographic risk scores
The angiographic area at risk was assessed by the
Modified Bypass Angioplasty Revascularisation Investi-
gation [12] and the modified Alberta Provincial Project
for Outcome Assessment in Coronary Heart Disease
[APPROACH] [13] jeopardy scores). Coronary angio-
grams were reviewed by two experienced observers
blinded to CMR scan and clinical data.
Interobserver variability
Each AAR calculation method was assessed with the
evaluator blinded to the results of other techniques. All
studies, both angiographic and CMR, were evaluated
separately by 2 cardiologists specialized in cardiac im-
aging and 2 interventional cardiologists to obtain the in-
terobserver variability of each AAR estimation method.
Statistical analysis
Baseline demographics and continuous variables are
summarized for 3-slice and 10-slice groups. Continuous
variables are presented as a mean ± SD and categorical
variables are presented as a percentage. 95 % confidence
intervals (CI) are given. Intra-observer variability and
correlation between methods was calculated using the
coefficient of intraclass correlation coefficient (ICC). All
p-values are 2-sided and a value of <0.05 was considered
to indicate statistical significance. The comparison of the
different correlation coefficients was performed using a
2-tailed Fisher’s z-transformation statistical analysis.
Data plotting used in analyzing the agreement between
the different methods was made with Bland-Altman ana-
lysis [19]. All statistical analyses were performed using
SPSS version 19 (IBM Corp. Armonk, NY, USA) and
graphs produced using Graphpad Prism version 5.0
(GraphPad Software, San Diego, CA).
Results
167 patients presenting with AMI undergoing PPCI at 3
European cardiac intervention centre {Barts Heart Centre,
UK; Centre Hospitalier Universitaire, Switzerland;
Rigshospitalet, Denmark), were included in the analysis.
The mean ages of patient was 56.2 ± 10 · 2 years and 88 %
were male. Clinical, CMR and angiographic characteristics
of the population are shown in Table 1. Patients under-
went either 10-slice (n = 85) or 3-slice (n = 82) T2-STIR
imaging for AAR assessment as previously described
(Additional file 1: Figure S1). The 2 groups were similar
with regards to age, sex, LVEF and medical therapy, due to
the inclusion criteria of the individual clinical studies there
were a greater number of left anterior descending artery
(LAD) occlusions in the 3 slice group. CMR was
performed at a median of 3 days (range: 2–3 days) after
PPCI. In all cases, increased signal intensity was detected
in T2-STIR as well as in late gadolinium enhancement
sequences.
Comparison of 3-slice and 10-slice AAR in the 10-slice
cohort
The 10-Slice AAR group underwent both 10-slice and 3-
slice analysis to directly compare the 2 techniques.
When assessing the 3-slice acquisition in the 10-slice co-
hort, all scans had the same level basal, mid and apical
slice assessed (defined as 2nd basal slice after the aortic
valve, 2nd slice with presence of papillary muscles de-
fined as the mid ventricle and penultimate slice within
the apex). Within the 10-slice AAR group the AAR
ranged from 11.5 % of the myocardium to 46.8 % (mean
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27.8 ± 7.3) and the 3-slice AAR assessment of the same
patients showed similar values ranging from 10.0 to
52.0 % (mean 27.9 ± 8.3) (p = 0.9800). There were strong
correlations between 3-slice AAR and 10-slice AAR in this
patient group (r = 0.92, p < 0.0001) (Fig. 2). Bland-Atman
assessment of the two assessment groups shows a low
limit of agreement (mean difference −0.03 ± 3.21 %, 95 %
limit of agreement, −6.3 to 6.3, containing 95.3 % (81/85)
of the difference scores). In addition there was a strong
correlation between 3-slice MM and 10-slice MM (r =
0.90, p < 0.0001) (Additional file 2: Figure S2).
Comparison of CMR assessed AAR size and angiographic
AAR
Angiographic risk assessment was performed for all pa-
tients in this study. In the 10-slice AAR group the BARI
angiographic risk score ranged from 10.5 % to 47.4 %
(mean 26.6 ± 10.1), and the APPROACH angiographic risk
score ranged from 6.5 % to 47.8 % (mean 29.2 ± 9.0 %) of
the left ventricle (LV) myocardium. There was good correl-
ation between the 2 angiographic risk scores (r = 0.85, p <
0.0001). There was a statistically significant correlation
with discrepant strength between the 10-slice AAR and the
APPROACH angiographic risk score (r = 0.46, p < 0.0001)
with a weaker correlation seen between the 10-slice AAR
and BARI angiographic risk score (r = 0.27, p = 0.0124)
(Fig. 3). For the 10-slice AAR group infarct and oedema
ESA was assessed for all patients, with Infarct ESA ranging
from 0 to 45 % (mean 17.3 ± 9.8 %) and oedema ESA ran-
ging from 10 to 44 % (mean 27.2 ± 7.8 %). There was a
strong correlation between 10-slice AAR and oedema EAS
(r = 0.79, p < 0.0001), there was a low correlation between
10-slice AAR and infarct EAS (r = 0.42, p < 0.0001).
In all 3-slice AAR studies the BARI angiographic risk
score ranged from 10.5 to 47.4 % (mean 30.9 ± 10.5) and
the APPROACH angiographic risk score ranging from 6.5
to 47.8 % (mean 33.4 ± 9.3 %) of the LV myocardium. As
was seen within the 10-slice group there was a good correl-
ation between the 2 angiographic risk scores (r = 0.88 p <
0.0001). Within the 3-slice AAR group the AAR ranged
from 3 to 56 % (mean 30.1 ± 9.8). The 3-slice AAR assess-
ment was correlated with both angiographic risk scores
(BARI: r = 0.36, p <0.0001, APPROACH; r = 0.42, p <
0.0001) (Fig. 4) (Table 2). For the 3-slice AAR group infarct
and oedema ESA was assessed, with infarct ESA ranging
from 1 to 57 % (mean 17.3 ± 9.7 %) and oedema ESA ran-
ging from 2 to 59 % (mean 29.1 ± 9.9 %). There was a
strong correlation between 3-slice AAR and oedema EAS
(r = 0.89, p < 0.0001), there was a low correlation between
3-slice AAR and infarct EAS (r = 0.45, p < 0.0001).
Comparison between infarct size and myocardial AAR
Scores
Infarct size as measured by CMR ranged from 1.0 % to
44.0 % of the LV myocardium (mean 18.0 ± 8.8 %). There
Fig. 2 Correlation coefficient between 3-slice AAR and 10-slice AAR.
Association between 3-slice STIR area at risk and 10-slice STIR area at
risk assessed by CMR on sub group 10-slice STIR group
Table 1 Baseline characteristics
3-slice 10-slice
(n = 82) (n = 85) P value
Age (yr) 57.0 ± 10.5 55.9 ± 11.4 0.6202
Sex (M/F) 71/11 75/12 0.3037
BMI (kg/m2) 27.0 ± 3.8 27.4 ± 3.9 0.5277
Ethnicity (Caucasian) (No. (%)) 66 (80 %) 71 (83.5 %) 0.6113
Medical History:
Hypertension (No. (%)) 30 (36.5 %) 28 (32.9 %) 0.6235
Hypercholesterolemia (No. (%)) 24 (29.3 %) 31 (26.4 %) 0.3251
Diabetes mellitus (No. (%)) 10 (12.2 %) 9 (11.6 %) 0.5766
Active smoker (No. (%)) 42 (51.2 %) 47 (55.3 %) 0.6004
Previous MI (No. (%)) 1 (1.2 %) 2 (2.4 %) 0.5841
Previous PCI (No. (%)) 1 (1.2 %) 3 (3.5 %) 0.3320
Family history (No. (%)) 25 (30.5 %) 19 (22.4 %) 0.2354
Culprit Vessel: <0.0001
LAD (No. (%)) 82 (100 %) 23 (27 %)
LCx (No. (%)) 0 (0 %) 11 (13 %)
RCA (No. (%)) 0 (0 %) 51 (60 %)
Timings:
Chest Pain to PCI (min) 194.5 ± 25.4 201.0 ± 32.2 0.8459
Infarct Size (%) 17.01 ± 8.88 18.02 ± 8.82 0.4543
AAR (%) 27.9 ± 8.3 27.27 ± 7.3 0.9800
Plus-minus values are mean ± SEM. No denotes number
BMI body mass index, AAR area at risk, LAD left anterior descending artery, LCx
circumflex artery, RCA right coronary artery
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was a significant correlation between infarct size and 10-
slice AAR (r = 0.73, p < 0.0001), with a lower correlation
seen between infarct size and 3-slice AAR studies (r = 0.48
p < 0.0001) (Fig. 5). Myocardial salvage was calculated for
both 3-slice and 10-slice assessments with no significant
difference between the two imaging modalities (41.30 % ±
22.41 % in the 3-slice group vs. 39.39 % ± 21.59 % in the
10-slice group; p = 0.5712) (Fig. 6).
Timing for acquisition and analysis of 3-slice versus
10-slice AAR
The time taken for the acquisition of the T2-STIR se-
quences was assessed from the initiation of the scan to
the start of the next imaging sequence. The 3-slice group
had a median acquisition time of 100 seconds (range:
65–171 seconds) and the 10-slice group had a median
acquisition time of 355 seconds (range: 275–603 sec-
onds), with a significant difference seen between the two
groups (p < 0.0001) (Fig. 7a).
For analysis the 3-slice group had a median time of
43 seconds (IQR: 36–56 seconds) and 10-slice group
had a median time of 137 seconds (IQR: 133–144 sec-
onds), with a significant difference seen between the two
groups (p < 0.0001). The inter-observer timing variability
Fig. 3 Scatter-plot of angiographic risk score versus 10-slice STIR AAR. Panel
a shows the relationship between 10-slice STIR area at risk assessed by
CMR and BARI angiographic risk. Panel b shows the relationship between
10-slice STIR area at risk assessed by CMR and APPROACH angiographic risk
Fig. 4 Scatter-plot of angiographic risk score versus 3-slice STIR AAR.
Panel a shows the relationship between 3-slice STIR area at risk
assessed by CMR and BARI angiographic risk. Panel b shows the
relationship between 3-slice STIR area at risk assessed by CMR and
APPROACH angiographic risk
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correlated well between analysers; 3-slice r = 0.96 p <
0.0001, 10-slice r = 0.93 p < 0.0001) (Fig. 7b).
Combined acquisition and analysis time showed a sig-
nificant difference between the two groups (p < 0.0001).
The median time of 143 seconds (IQR: 131–171 sec-
onds) in the 3-slice group was on average 5 minutes
quicker than the 10-slice group (median time of 492 sec-
onds (IQR: 472–565 seconds).
Overall scan time was taken from initiation of first
scouting image to the end of the final image. Within the
3-slice group there was a median time of 2163 seconds
(IQR: 1740–2520 seconds) and 10-slice group had a me-
dian time of 2448 seconds (IQR: 1986–2835 seconds),
with a significant difference seen between the two
groups (p = 0.0057).
Inter-observer variability
3-slice STIR imaging showed low inter-observer variabil-
ity. For the Bland-Altman plot, the 95 % limits of agree-
ment (−5.3 %, 3.6 %) contained 95.1 % (78/82) of the
difference scores. The mean bias of the measurements
between observers was 0.08 %, and the maximum and
minimum difference was 8.0 % and −7.0 % respectively
(Fig. 8). The 10-slice STIR imaging showed similar inter-
observer variability (z = 1.035, p = 0.15). For the Bland-
Altman plot, the 95 % limits of agreement (−4.68 %,
4.04 %) contained 94.1 % (80/85) of the difference
scores. The mean bias of the measurements between ob-
servers was −0.32 %, and the maximum and minimum
difference was 5.0 % and −5.6 % respectively.
Discussion
Oedema CMR imaging using T2-STIR remains an import-
ant technique to quantify the AAR. The aim of this study
was to validate a 3-slice oedema CMR quantification of
the myocardial AAR following PPCI for STEMI. We dem-
onstrated that 3-slice quantification remains accurate for
the detection of myocardial oedema after an AMI when
compared to the conventional 10-slice technique with no
significant bias demonstrated in assessing the AAR. The
3-slice technique also requires less time to acquire and
analyse compared to the conventional 10-slice approach.
Oedema CMR using T2-STIR imaging remains popu-
lar for assessing myocardial oedema [20] and the AAR
after AMI, with studies showing the superiority of the
clinical use of oedema CMR imaging in both AMI and
chronic heart disease [4, 21]. The benefit of oedema
CMR assessment over previous AAR assessment such as
single-photon emission computed tomography (SPECT)
is the lack of ionising radiation or the need for tracer ad-
ministration. Although the benefit of SPECT imaging
processes removes the issues of claustrophobia that is
found in CMR imaging. The majority of these studies
have used 10–12 slice oedema CMR covering the whole
left ventricle, however due to the need for adequate
breath holding techniques and the possibility of artefact
the overall image acquisition time is long for the 10-slice
STIR imaging technique.
Previous studies have demonstrated the suitability of
3-slice imaging in the assessment of myocardial scar as
well as LV volumes [22]. However this is the first study
to assess whether or not the AAR can also be assessed
using a 3-slice technique, demonstrating the technique
is comparable to the conventional 10-slice approach.
The main benefit of the 3-slice oedema CMR in com-
parison to 10-slice oedema CMR is a quicker acquisition
and analysis time. The overall scan time was nearly 5 mi-
nutes shorter with the 3-slice oedema sequence com-
pared to the longer 10-slice sequences. The difference of
over 5 minutes due to a shorter acquisition time and
Table 2 Intraclass correlation coefficients between angiographic and cardiovascular magnetic resonance methods of 3-slice and 10-
slice oedema CMR (T2-STIR) imaging techniques
3-slice Assessment T2 STIR APPROACH BARI
Infarct ESA 0.50 (0.30–0.66)*** 0.27 (0.12–0.41)** 0.19 (0.05–0.34)**
Oedema ESA 0.91 (0.86–0.95)*** 0.36 (0.22–0.49)** 0.27 (0.12–0.41)*
Infarct % 0.47 (0.26–0.64)*** 0.28 (0.13–0.41)** 0.20 (0.05–0.35)*
BARI 0.35 (0.21–0.49)*** 0.88 (0.85–0.91)***
APPROACH 0.42 (0.29–0.55)***
10-slice Assessment T2 STIR APPROACH BARI
Infarct ESA 0.64 (0.50–0.75)*** 0.44 (0.25–0.60)*** 0.28 (0.07–0.47)**
Oedema ESA 0.89 (0.84–0.93)*** 0.40 (0.20–0.56)*** 0.17 (–0.05–0.37)
Infarct % 0.73 (0.61–0.82)*** 0.50 (0.32–0.64)*** 0.33 (0.13–0.51)**
BARI 0.27 (0.06–0.46)*** 0.85 (0.78–0.90)***
APPROACH 0.46 (0.27–0.61)***
Data are expressed intraclass correlation coefficients (confidence interval). p value <0.05 = *, <0.01 = **, <0.001 = ***. APPROACH Alberta provincial project for
outcome assessment in coronary heart disease, BARI bypass angioplasty revascularization investigation myocardial jeopardy index, ESA endocardial surface area,
STIR T2, short tau inversion recovery, LAD left anterior descending artery
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analysis time would have clinical benefit. The use for only
3 breath holds in comparison to the 10 or 12 without loss
of required clinical information is of benefit especially in
patients who have issues including claustrophobia or who
are unable to lie flat for extended periods. These are com-
mon factors in patients 3 days post primary PCI for AMI.
The benefit that could be applied to patients could also be
seen finically by performing 3-slice AAR in the clinical
setting. In a busy CMR centre where multiple clinical
scans are performed each day the reduction of acquisition
time could result in additional scans being performed and
improved financial incentive. In addition the timing for
analysis was significantly shorter within the 3-slice ap-
proach without the loss of significant clinical information,
which may be of benefit when multiple analysis are re-
quired thus reducing analysis times in large quantity
analysis.
The assessment of AAR has become increasingly im-
portant when testing potentially cardioprotective therap-
ies. Conventional imaging techniques in such trials tend
to assess changes in left ventricular ejection fraction for
their surrogate endpoint that require multiple visits. The
use of a single AAR image acquisition at an early time
point could possibly reduce the need for multiple scans
and give early results without the need for protracted
follow up. Although more information maybe required
in the research setting the shorter image analysis times
could have be an important factor when assessing mul-
tiple images within a study.
One particular issue with T2-STIR imaging is the false
signal that occurs in area of blood pooling especially in pa-
tients with poor LV function [23]. In the apical segments of
the LV there is increased blood pooling causing greater
sub-endocardial bright artefact during myocardial quantifi-
cation. The imaging technique for 10-slice acquisition
takes single contiguous 1 cm slices from mid atria to true
apex, whereas the 3-slice acquisition takes a slice in the
basal, mid and apical segment of the LV therefore reducing
true apical blood pooling (Additional file 3: Figure S3). The
observer variability was similar in the 3 slice and 10-slice
acquisition groups. This implies that the use of 3-slice ac-
quisition imaging may not result in the loss of important
Fig. 5 Correlation coefficient between infarct size and AAR. Panel a
shows the association between 3-slice STIR area at risk assessed by
CMR and infarct size. Panel b shows the association between 10-slice
STIR area at risk assessed by CMR and infarct size
Fig. 6 Myocardial salvage assessment between 3-Slice and 10-Slice
technique. Panel a shows the relationship between 3-slice STIR area at
risk assessed by CMR and infarct size. Panel b shows the relationship
between 10-slice STIR area at risk assessed by CMR and infarct size
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clinical information and may reduce the issue of increased
signal from pooled blood in comparison to 10-slice acquisi-
tion. Although T2-STIR imaging has been used widely
other methods or programming techniques are available to
reduce acquisition time such as navigator gated imaging
technique and the use of early gadolinium enhancement
that could be beneficial in the clinical setting.
In summary the advantages of 3-slice oedema CMR
imaging over 10-slice imaging in assessing myocardial
AAR are: 1) equal clinical information; 2) reduced imaging
protocol time; 3) reduced breath holding time; and 4) re-
duced combined acquisition and analysis time.
Study limitations
The present study was performed on a small limited pa-
tient population in patients who after suffered a STEMI
and underwent successful PPCI with the majority of pa-
tients receiving a novel cardioprotective intervention at
the time prior to undergoing CMR imaging within
3 days. One of the studies included in the analysis re-
cruited only patients with anterior infarcts due to oc-
clusions of the LAD which may have lead to bias in
the results.
Conclusions
This study was able to validate 3-slice oedema CMR
quantification of AAR showing good correlations with
current full coverage imaging techniques. The quicker
and easier analysis method is advantageous for both pa-
tients and clinicians and could shorten acquisition time
in patients who are either claustrophobic or have diffi-
culty with breath holding technique.
Fig. 7 Comparison of acquisition a and analysis b time between 3-slice and 10-slice imaging technique. Panel a shows the relationship between
3-slice STIR area at risk assessed by CMR and infarct size. Panel b shows the relationship between 10-slice STIR area at risk assessed by CMR and
infarct size
Fig. 8 Bland-Altman plot for the inter-observer variability of the 3-slice STIR AAR assessment
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